Abstract: Strain-promoted inverse electron-demand DielsAlder cycloaddition (SPIEDAC) reactions between 1,2,4,5-tetrazines and strained dienophiles, such as bicyclononynes, are among the fastest bioorthogonal reactions. However,t he synthesis of 1,2,4,5-tetrazines is complex and can involve volatile reagents. 1,2,4-Triazines also undergo cycloaddition reactions with acyclic and unstrained dienophiles at elevated temperatures, but their reactionw ith strained alkynes has not been described. We postulated that 1,2,4-triazinesw ould react with strained alkynes at low temperatures and therefore provide an alternative to the tetrazine cycloaddition reaction for use in in vitro or in vivo labelling experiments. We describet he synthesis of a1 ,2,4-triazin-3-ylalanine derivative fully compatible with the fluorenylmethyloxycarbonyl (Fmoc) strategyf or peptides ynthesis and demonstrate its reaction with strained bicyclononynes at 37 8Cw ith rates comparable to the reactiono fa zides with the same substrates. The synthetic route to triazinylalanine is readily adaptable to latestage functionalization of other probe molecules, and the 1,2,4-triazine-SPIEDACt herefore has potential as an alternative to tetrazine cycloaddition for applicationsi nc ellular and biochemical studies.
Introduction
Strain-promoted inverse electron-demand Diels-Alder cycloaddition (SPIEDAC) between1 ,2,4,5-tetrazines and strained alkenes and alkynes are the fastestk nown bioorthogonal conjugation reaction. For example, tetrazines (Scheme 1, X = N) react with strained cycloalkynes to form pyridazine productsvia asequentiali nverse electron-demand hetero-Diels-Alder (ihDA) retro-Diels-Alder (rDA) cascade. [1] Because this class of reactions proceeds with rate constantsr anging from 1-10 5 m À1 s À1 [2, 3] and gives no toxic by-products, they have become the reaction of choice for in vivo studies. [4] [5] [6] [7] [8] This class of cycloaddition has now been appliedi nm ultiple applications including intracellulari maging, [4] in vivo imaging, [6, 8] live labelling of cell-surface antigens, [7] as well as the modification of cells with nanomaterials for clinicaldiagnostics. [5] Although tetrazine SPIEDAC reactions are rapid and efficient, production of functionalised tetrazine scaffolds remains syntheticallyc hallenging in comparison to triazine alternatives. Unsymmetrical aromatic and aliphatic tetrazines can either be accessed inefficiently through the Pinners ynthesis, [2, 9] or via S N Ar reaction of ap reformed symmetrical tetrazine, and ac orresponding multistep synthesis. [10] [11] [12] [13] [14] The more efficient optimised routes to substituted tetrazines involvev olatile precursors and intermediates;f or example, the use of anhydrous hydrazine in the metal-mediated synthesis of aliphatic tetrazines described by Yang et al., [15] or the "highly energetic" 3,6-dihydrazino-1,2,4,5-tetrazine intermediate in the synthesis of 3,6-dichloro-1,2,4,5-tetrazine. [14] In some cases, the tetrazine derivatives required for late-stage functionalisation are readily decomposed, for example, 3,6-dimethyldicarboxylate-1,2,4,5-tetrazine is prone to acid-promoted rearrangement and slowly decomposes upon warming [16] and 3,6-dimethylthio-and 3,6-dichlorotetrazines are incompatible with organometallic species. [17] Furthermore, somet etrazinesa re prone to either hydrolysis [9] or decomposition into the corresponding pyrazoles or thiazoles when exposed to endogenous cellular nucleophiles. [18] Cycloadditionr eactions have also been reported to occur between 1,2,4-triazines (Scheme 1, X = CH) and dienophiles to form dihydropyridine and pyridine derivatives. [19, 20] The earliest examples of 1,2,4-triazine cycloaddition reactions involved their conjugation to simple nitriles. [21] More recently,a ttention has been focused on exploiting the reaction to access ar ange of polycyclic and fused heterocyclest hrough tethered triazine Scheme1.SPIEDACb etweenatetrazine (1,X= N) or atriazine (1,X= CH) and astrained cycloalkyne 2.Rate-determining [4 + 2] cycloaddition between 1 and 2 ledtot he highly strained bicyclicadduct 3,which undergoes ac ycloreversiony ielding pyridazine (4,X= N) or pyridine-(4,X= CH) products and releasing dinitrogen.
alkyne/alkene scaffolds. [20, 22] Although this cycloaddition is now commonlyu sed in elegant synthetic routes to providec omplex pyridyl-containing structures, the need for elevated temperatures (mostly exceeding 100 8C) and extended reaction times meanst hat it has never been considered for cellular applications.1 ,2,4-Triazine and 1,2,4,5-tetrazine conjugations are controlled by the HOMO dienophile -LUMO diene gap;d ienophiles with ah igh degree of ring strain reduce the activation energy of the [4 + 2] cycloaddition RDS by raisingt he HOMO dienophile and decreasing the distortion energy neededt or each the cycloaddition transition state. [23, 24] To date, nearly all examples of 1,2,4-triazine cycloaddition reactions involve open chain and unstrained cyclic dienophiles. Until recently, [25] there were no reports of a1 ,2,4-triazine SPIEDACr eactionw iths trained dienophiles other than norbornadiene. [26, 27] Based on the understanding that strained dienophiles increase the reaction rate for cycloaddition with 1,2,4,5-tetrazines, we proposed that the conjugation of as trained cycloalkane/alkyne with a1 ,2,4-triazine derivative would also proceed withoutt he need fore levated temperatures, and could thus offer an alternative to 1,2,4,5-tetrazine SPIEDAC for use in ar ange of in vitro and in vivo applications. We envisagedt hat this alternative, although slower, would obviatet he need for toxic and volatile precursors and increase the range of probe molecules that could be generated. Herein, we report the synthesis of an ew 1,2,4-triazinylalanine (TrzAla) derivative 13 (Scheme 2iii), which is compatible with the fluorenylmethyloxycarbonyl (Fmoc) solid-phase peptides ynthesis (SPPS) strategy, demonstrate its incorporation into am odel probe peptide 14 and determine the rate of reaction of these compounds to ar epresentative dienophile bicyclononyne 19.T his reaction has the potentialf or direct applicationf or conjugation to genetically incorporated bicyclononyne-containinga mino acids in future applications.
Results and Discussion
Our initial aim was to synthesise at riazine with af unctional group handle suitable for rapid derivatisationo ft arget molecules. We initially synthesised 6-substituted3 -amino-1,2,4-triazines 5a-c (Scheme 2i)w itht he aim of generating molecules of the form 8 via amide bond coupling.H owever,t he low nucleophilicity of the exocyclica mine meantt hat we were able to generate the protected succinylamidotriazine 7 in only 1% yield over two steps. In general, the de novo synthesis of triazines by controlled condensation between aminoguanidine and glyoxal derivatives (Scheme 2i)i sl ow yielding andg ives mixtureso fi somers;h owever,t he aminotriazine derivative 5a is now commerciallya vailablei nl arge quantities, and we therefore used this as the basis for subsequentreactions (Scheme 2ii).
Jackson and co-workersh ave reported the synthesis of enantiomerically pure pyridylalanine amino acids through palladium-catalysed cross-coupling of serine-derived organozinc reagentsw ith halopyridyl derivatives. [28, 29] We postulated that Negishi-type cross-coupling could be extendedt oi nclude other N-heterocycles, andt herefore devised as ynthetic strategy (Scheme 2iii)t hat utilised iodotriazine 9 as the electrophilic couplingp artner.I odotriazine 9 was formed through diazotisationo fa minotriazine with isopentyl nitrite in diiodomethane (Scheme 2ii). [30] Fmoc-iodoalaninem ethyl ester 11 was synthesised in three steps from serine methyl ester 10. [28] For Negishic ross-coupling, commercialz inc dust was activated with iodine in anhydrous DMF.T he use of ad ipolar aprotic solvent, such as DMF prevents coordination of the carScheme2.i) Condensation of aminoguanidineand av ariety of substituted glyoxal derivatives to make substituted 3-amino-1,2,4-triazines 5a-c and subsequent conversion in low yield to amide linked scaffolds. ii)Conversion of commercial 3-amino-1,2,4-triazine 5a to 3-iodo-1,2,4-triazine 9 by direct iodination. iii)Synthetic route from serine methyle ster 10 to Fmoc-compatible building block Fmoc-TrzAla-OH 13 and subsequent incorporation into ap eptide.
Chem. Eur.J.2015, 21,14376 -14381 www.chemeurj.org bamate carbonyl group to zinc, and therefore promotes belimination (by coordination to the carbonyl methyl ester) to form the organozinc reagent. [31] Zinc insertion of iodoalanine methyl ester 11 wasc omplete after two hours at room temperature( determined by loss of the iodoalanine by TLC), and the subsequentc ross-coupling with iodotriazine 9 was performed using catalytic amounts of palladium(II) acetate and 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (SPhos). This gave the desired triazinylalanine methyl ester 12 in ay ield of 69 %. Limited attempts to optimise this coupling by increased catalystl oading and the alternative palladium catalyst (tris(dibenzylideneacetone)dipalladium(0)) didn ot lead to significant increasesi ny ield. Demethylation of the methyl ester 12 to give the free acid 13 was carriedo ut using trimethyltin hydroxide [32] in ay ield of 27 %. In this case, the overall isolated yield is limited by observable degradation of the triazines 12 and 13 at the elevated temperatures required for deprotection. (Note that base-catalysed deprotection with LiOH leads to concomitantF moc-group removal.) To demonstrate the compatibility of the protected triazinylalanine with the conditions for the Fmoc strategy for solid-phase peptides ynthesis, we generated as imple fluorescein isothiocyanate (FITC)-labelled peptide 14 using Rink amide resin and on-resin fluorescencel abelling in 37 %y ield following HPLC purification.
We next evaluated suitable cycloaddition partners to couple to our 1,2,4-triazine derivatives 12 and 13.T here are an umber of strained cyclic dienophiles reported for tetrazineS PIEDAC conjugations( with rate constants spanning five orders of magnitude). [2, 3] We initially investigated the cycloaddition reaction with norbornene,w hich reacts with tetrazine with ar elatively slow rate constant (1-10 m À1 s
À1
). [2] We used the methyl ester 12 for rate determination to avoid potentiali nterference from the free acid in 13.W ef irst synthesised norbornenyl-lysine 15 accordingt ot he procedure of Lang et al. [2] ,b ut could not detect formation of reaction product between 12 and 15 following prolonged incubation up to 80 8C( below the temperature at which we had observed thermald egradation of the triazines;S cheme 3i). To ensure that the unprotected norbornenyl-lysine 15 was not interfering with our analysis,w ec onfirmed that unfunctionalised norbornene 16 also did not reactu nder these conditions. The unhindered,s trainedb icyclo[6.1.0]nonynes react more rapidly with tetrazines with approximate rate constantso f 10 2.5 -10 3.5 m À1 s À1 ; [3] only exceeded by the rates of reactiont o trans-cyclooctenes. We generated benzoyl-protected bicyclononyne 19 (Scheme 3ii) by adaptation of the synthetic route of Dommerholt et al.; [33] following rhodium-catalysed cyclopropanation of 1,5-cyclooctadiene to yield am ixture of the anti-and syn-bicyclononene ethyl esters 17 and 17 b, anti-bicyclononene ethyl ester 17 was converted to bicyclononylol 18 (Scheme 3ii) by sequential reduction, dibrominationa nd double elimination, followed by protection using benzoyl chloridetogive alkyne 19. [34] We initially assessed the reaction of the protected bicyclononyne 19 with 12 at high concentration (65 mm in dichloromethane). Incubation of an equimolar mixture of the two reaction components yieldeda1 :1 mixture of the bicyclononapyridyl derivatives 20 a and b in 38 %y ield after 12 ha t3 78Ct ogetherw ith unreactedt riazine 12 (Scheme 3iii). In this case, the reactionw as limited by apparent degradation of the bicyclononyne coupling partner (as was determined by NMR). Next, we assessed the reaction rate at lower concentrations by determining the rate of product formation by HPLC, using the purifiedm ixture of authentic 20 a and b as ac oncentration standard ( Figure 1 ). Product formation in MeCN was measured over approximately 18 hu sing 1mm 12 and increasing concentrationso ft he bicyclononyne 19.G lobal fitting of the data gave an estimate for the second-order rate constant k 2 of 2.30 AE 0.03 10 À2 m À1 min À1 .C ompounds 12 and 19 are poorly water soluble, preventing us from carrying out the analogous experiment in water;h owever,t he reaction rate in 10 %H 2 O/ MeCN (see the Supporting Information) increased slightly to 3.0 AE 0.03 10 À2 m À1 min À1 suggesting that the rate in biological media will be slightly higher, consistent with other examplesoft his class of reaction. [35, 36] Comparison of this rate of reaction (0.3-0.5 10 À3 m À1 s
)t o other reactions in this class [37] suggestst hat although the cycloaddition of triazines with bicyclononynes is much slower than the corresponding reactiono ft etrazines, it is comparable [25] Over ar ange of triazine substrates, they observe reactionr ates of between 1a nd 710 À2 m À1 s
-approximately 30-fold higher than those we have determined. Thisr atio is similart ot he approximately 15-foldd ifference in rate observed for the reaction of tetrazines with bicyclononyne and trans-cyclooctene substrates by Lang et al. [3] and Kamber et al. observations are therefore fully consistent with our observed reaction rates.
Conclusion
We have defined ar oute to 1,2,4-triazin-3-yl-linked amino acids compatible withc onventional peptide-synthesis strategies using readily available and inexpensive starting materials as precursors. The alkyl triazine reacts readily with the strainedb icyclononyne dienophile at 37 8Ci ndicating that it is suitable for protein-labelling applications.T he synthetic strategy adopted can be readily adapted to generate triazine-linked scaffolds at al ate stage. The amino acidi ss imilari ns tructure to ar ange of tyrosine-based scaffolds that have been genetically incorporated into proteins in response to an amberc odon using evolvedt yrosyl-tRNA synthetases. [38, 39] We hypothesise that that it will be possible to identify such systems as hasb een recently demonstrated for triazinylphenylalanine by Kamber et al. [25] But because strategies to incorporate bicyclononynecontaining amino acids into proteins are already established, [40] this is not al imiting factor for application to site-specific labelling in an in vitro or in vivo context.
Experimental Section
General chemical experimental details procedures for synthesis of compounds 5a, b, c, 6, 7, 10, 11, 14, 17 a, 18 and 19,a nd protocols for rate determination can be found in the Supporting Information.
Synthesis of 3-iodo-1,2,4-triazine (9) Isoamyl nitrite (42 mL, 300 mmol, 14 equiv) was added to as tirred solution of 3-amino-1,2,4-triazine 5a (2 g, 20 mmol, 1e quiv) in diiodomethane (ca. 40 mL). [30] The turbid orange mixture was stirred at 55 8Cf or 4h,a llowed to cool, filtered at the pump and concentrated as far as possible in vacuo to leave the product and residual unreacted diiodomethane (ca. 30 mL). The remaining filtrate was applied to as ilica column and purified by column chromatography eluting with 3:1h exanes/EtOAc. The resultant orange solid was dissolved in 1,4-dioxane and lyophilised to give the product ( Synthesis of Fmoc-TrzAla-OMe (9H-fluoren-9-yl)methyl (S)-1-(methoxycarbonyl)-2-(1,2,4-triazin-3-yl)ethylcarbamate (12) To an oven-dried two-neck flask, zinc dust (1.16 g, 18 mmol, 3equiv) was added;t he flask was evacuated, dried with af lame and purged with nitrogen three times. [28] The flask was allowed to cool to room temperature, dry DMF (18 mL) and iodine (225 mg, 0.89 mmol, 0.15 equiv) were added in quick succession. The solution became orange, and after two minutes returned to grey.A fter 15 min, iodoalanine 11 (2.67 g, 5.9 mmol, 1e quiv) was added, followed immediately by iodine addition (225 mg, 0.89 mmol, 0.15 equiv), and the mixture was stirred at room temperature. After two hours, zinc activation was shown to be complete by TLC (2:1 hexanes/EtOAc) and 3-iodo-1,2,4-triazine (9;1 .59 g, 7.68 mmol, 1.3 equiv), palladium(II) acetate (33 mg, 0.15 mmol, 0.025 equiv) and 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl (SPhos) (121 mg, 0.30 mmol, 0.05 equiv) were added to the flask in quick succession. The flask was heated to 50 8Ca nd stirred for five hours, the reaction was allowed to cool and filtered through aC elite pad, which was washed several times with CH 2 Cl 2 .The resultant solution was concentrated in vacuo, and the pale orange solid was purified by column chromatography on silica gel, eluting initially with 4:1 hexanes/EtOAc and then EtOAc. The combined fractions were concentrated in vacuo and lyophilised to give Fmoc-TrzAla-OMe (1.66 g, 4.12 mmol, 69 %) as af locculent, pale orange solid. [ Synthesis of Fmoc-TrzAla-OH (9H-fluoren-9-yl)methyl (S)-1-(carboxy)-2-(1,2,4-triazin-3-yl)ethylcarbamate (13) Fmoc-TrzAla-OMe (12;3 00 mg, 0.74 mmol, 1equiv) and trimethyltin hydroxide (402 mg, 2.2 mmol, 3equiv) were dissolved in anhydrous C 2 H 4 Cl 2 (9 mL) and heated at reflux for 2.5 h, until the deprotection was shown to be complete by TLC (EtOAc). [32] The reaction was allowed to cool to room temperature and quenched with H 2 O( 15 mL). The organic layer was extracted with CH 2 Cl 2 (3 20 mL), and the combined organic layers were washed with H 2 O (1 20mL), brine (2 20mL), dried (MgSO 4 )a nd concentrated in vacuo. The orange oil was purified by column chromatography on silica gel (95:4:1 CH 2 Cl 2 /MeOH/AcOH) and lyophilised to give Fmoc-trzAla-OH (78 mg, 0.19 mmol, 27 %) as ap ale yellow,f locculent solid. [a] 
